Rhythm Pharmaceuticals Stock Market Value
| RYTM Stock | USD 64.06 1.52 2.32% |
| Symbol | Rhythm |
Rhythm Pharmaceuticals Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Rhythm Pharmaceuticals. If investors know Rhythm will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Rhythm Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.32) | Revenue Per Share 1.863 | Quarterly Revenue Growth 0.478 | Return On Assets (0.46) | Return On Equity (1.48) |
The market value of Rhythm Pharmaceuticals is measured differently than its book value, which is the value of Rhythm that is recorded on the company's balance sheet. Investors also form their own opinion of Rhythm Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Rhythm Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Rhythm Pharmaceuticals' market value can be influenced by many factors that don't directly affect Rhythm Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Rhythm Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Rhythm Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Rhythm Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Rhythm Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Rhythm Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Rhythm Pharmaceuticals.
| 11/24/2022 |
| 11/13/2024 |
If you would invest 0.00 in Rhythm Pharmaceuticals on November 24, 2022 and sell it all today you would earn a total of 0.00 from holding Rhythm Pharmaceuticals or generate 0.0% return on investment in Rhythm Pharmaceuticals over 720 days. Rhythm Pharmaceuticals is related to or competes with Revolution Medicines, Akero Therapeutics, Avidity Biosciences, Protagonist Therapeutics, Stoke Therapeutics, Uniqure NV, and Rocket Pharmaceuticals. Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercializa... More
Rhythm Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Rhythm Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Rhythm Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.64 | |||
| Information Ratio | 0.134 | |||
| Maximum Drawdown | 13.98 | |||
| Value At Risk | (3.65) | |||
| Potential Upside | 7.37 |
Rhythm Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Rhythm Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Rhythm Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Rhythm Pharmaceuticals historical prices to predict the future Rhythm Pharmaceuticals' volatility.| Risk Adjusted Performance | 0.1507 | |||
| Jensen Alpha | 0.2574 | |||
| Total Risk Alpha | (0.08) | |||
| Sortino Ratio | 0.1653 | |||
| Treynor Ratio | 0.28 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Rhythm Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Rhythm Pharmaceuticals Backtested Returns
Rhythm Pharmaceuticals appears to be very steady, given 3 months investment horizon. Rhythm Pharmaceuticals maintains Sharpe Ratio (i.e., Efficiency) of 0.17, which implies the firm had a 0.17% return per unit of risk over the last 3 months. By analyzing Rhythm Pharmaceuticals' technical indicators, you can evaluate if the expected return of 0.56% is justified by implied risk. Please evaluate Rhythm Pharmaceuticals' Semi Deviation of 2.15, coefficient of variation of 537.87, and Risk Adjusted Performance of 0.1507 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Rhythm Pharmaceuticals holds a performance score of 13. The company holds a Beta of 2.13, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Rhythm Pharmaceuticals will likely underperform. Please check Rhythm Pharmaceuticals' maximum drawdown, skewness, as well as the relationship between the Skewness and day typical price , to make a quick decision on whether Rhythm Pharmaceuticals' historical price patterns will revert.
Auto-correlation | 0.33 |
Below average predictability
Rhythm Pharmaceuticals has below average predictability. Overlapping area represents the amount of predictability between Rhythm Pharmaceuticals time series from 24th of November 2022 to 19th of November 2023 and 19th of November 2023 to 13th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Rhythm Pharmaceuticals price movement. The serial correlation of 0.33 indicates that nearly 33.0% of current Rhythm Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.33 | |
| Spearman Rank Test | -0.17 | |
| Residual Average | 0.0 | |
| Price Variance | 33.01 |
Rhythm Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Rhythm Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Rhythm Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of Rhythm Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Rhythm Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Rhythm Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Rhythm Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Rhythm Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Rhythm Pharmaceuticals stock over time.
Current vs Lagged Prices |
| Timeline |
Rhythm Pharmaceuticals Lagged Returns
When evaluating Rhythm Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Rhythm Pharmaceuticals stock have on its future price. Rhythm Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Rhythm Pharmaceuticals autocorrelation shows the relationship between Rhythm Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in Rhythm Pharmaceuticals.
Regressed Prices |
| Timeline |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Rhythm Pharmaceuticals Correlation, Rhythm Pharmaceuticals Volatility and Rhythm Pharmaceuticals Alpha and Beta module to complement your research on Rhythm Pharmaceuticals. To learn how to invest in Rhythm Stock, please use our How to Invest in Rhythm Pharmaceuticals guide.You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Rhythm Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.